endovascular.es

Título: First Ten Patients Enrolled in U.S. Clinical Study that is Evaluating Treatment of Iliofemoral Venous Outflow Obstruction
Fecha: 03-03-2014
Bloomington, Ind.— The first ten patients have been enrolled in Cook Medical’s VIVO clinical research study. The study is designed to evaluate the safety and effectiveness of treating symptomatic iliofemoral venous outflow obstruction with the Zilver® Vena™ Venous Self-Expanding Stent. The trial’s first patients are undergoing treatment at six healthcare facilities in the East Coast and Midwest regions. Dr. Charles B. Ross, chief of vascular and endovascular services at Piedmont Heart Institute was the first physician to enroll a patient in the study.
“Cook sees this as an important step in the battle against iliofemoral venous outflow obstruction,” explained Mark Breedlove, vice president and global leader of Cook’s Peripheral Intervention clinical division. “By conducting the VIVO clinical research study, we hope to advance our understanding of venous disease while providing new treatment options for patients.”
Fuente: endovascular.es

endovasculares.es